Our point of difference
BioPacificVentures is a venture investment fund specialising in food, agriculture, health & wellness, operating across Australia & New Zealand, where rich innovation occurs in these fields.
A surprising amount of globally prominent new products in these fields can trace their beginnings to this region. At BioPacific we cover this field exhaustively, aiming to identify innovations from this region that can address major unmet needs. Then we add our expertise and capital, and work unstintingly alongside the entrepreneurs or inventors to achieve success.
Our capital pool is predominantly provided by corporations with an interest in food, agriculture, health & wellness, but also by financial institutions. This has given us strength from both ends of the spectrum – entry into global markets along with strong financial discipline along the way.
In many ways we are a hybrid compared to traditional venture capital – attentive to both our entrepreneurs and our investors, and spanning the spectrum from invention to market in our special area of expertise.
It is this unique combination that makes BioPacificVentures different.
Who you’re dealing with
BioPacificVentures is part of the Direct Capital group of funds, operated by 20-year veterans in private investment with a very strong track record.
BioPacific operates in the same way as a normal venture fund with a pool of investment managed by an expert team. Our investors don’t dictate where or how we invest, but they do add value once we have.
Among our corporate investors are Nestlé, the world’s largest food company, PGG Wrightson, New Zealand’s largest agribusiness and a large life science R&D firm called AgResearch who played a significant role in our creation. We also attracted funds from the New Zealand Government’s Venture Investment Fund and a range of institutional investors.
Similarly our team was assembled to create deep expertise and hard-earned respect. While we have come from diverse backgrounds which complement each other (science, business & finance) we all have deep experience in the pipeline of life science, from invention to market.